Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2014British Journal of HaematologyOpen Access

Intensification treatment based on early FDG ‐ PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trial

View Full Paper
Ask AI
Bookmark
Share

Authors

EPEmilia PardalHospital Virgen del PuertoMCMónica CoronadoHospital Universitario La PazAMAlejandro Martı́nUniversity of Alicante

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pardal et al. (2014) studied this question.

synapsesocial.com/papers/6aa92fb6c924504423cdc511https://doi.org/10.1111/bjh.13036
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Midtreatment <sup>18</sup>F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma2010 · 64 citations
  2. 2Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte2010 · 1,590 citations
  3. 3Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy2009 · 231 citations
  4. 4Interim18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation – where do we stand?2009 · 43 citations
  5. 5SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma2011 · 303 citations